http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0842924-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-75 |
| filingDate | 1997-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d2a29f1e9914aef7262f20589205d26 |
| publicationDate | 1998-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0842924-A1 |
| titleOfInvention | Pyridine intermediates, useful in the synthesis of beta-adrenergic receptor agonists |
| abstract | The present invention relates to certain compounds of the formula (I),n nwhich are useful in the synthesis of certain β-adrenergic receptor agonists. Theninvention also relates to a process for synthesizing the compounds of formula (I) and toncompounds of the formula (II),n nwherein R 1 , R 2 and R 4 are defined herein, which are useful in the synthesis of thencompounds of formula (I). The invention also relates to a process for synthesizing ancompound of formula (II). The invention further relates to processes for synthesizingncompounds of formula (Z*),n nR 1 , R 2 and Y 2* are defined herein. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005092860-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6642387-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1153919-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7375100-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1153919-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6515134-B1 |
| priorityDate | 1996-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 425.